Westminster Pharmaceuticals LLC
Westminster Pharmaceuticals LLC appears in FDA public data with 10 recalls — including 5 Class I (most serious) —, 0 510(k) clearances, 1 FDA inspection, and 0 compliance actions on record. Its most recent recall (D-0581-2025, Class II) was initiated on August 6, 2025.
Summary
- Total Recalls
- 10 (5 Class I)
- 510(k) Clearances
- 0
- Inspections
- 1
- Compliance Actions
- 0
Recent Recalls
| Number | Class | Product | Date |
|---|---|---|---|
| D-0581-2025 | Class II | Metoprolol Tartrate Tablets, USP, 50 mg, 1000 Tablets, Rx Only, Manufactured by: Renata PLC (General | August 6, 2025 |
| D-0582-2025 | Class II | Metoprolol Tartrate Tablets, USP, 100 mg, 1000 Tablets, Rx Only, Manufactured by: Renata PLC (Genera | August 6, 2025 |
| D-0301-2019 | Class II | Westminster Irbesartan Tablets, USP 150 mg Rx Only Manufactured by: ScieGen Pharmaceuticals, Inc. Ha | October 29, 2018 |
| D-0302-2019 | Class II | Westminster Irbesartan Tablets, USP 300 mg Rx Only Manufactured by: ScieGen Pharmaceuticals, Inc. Ha | October 29, 2018 |
| D-0300-2019 | Class II | Westminster Irbesartan Tablets, USP 75 mg Rx Only Manufactured by: ScieGen Pharmaceuticals, Inc. Hau | October 29, 2018 |
| D-1179-2018 | Class I | Levothyroxine and Liothyronine (Thyroid Tablets, USP), 1 & 1/2 grain (90 mg), 100-count bottles, Rx | August 3, 2018 |
| D-1182-2018 | Class I | Levothyroxine and Liothyronine (Thyroid Tablets, USP), 2 grain (120 mg), 100-count bottles, Rx Only, | August 3, 2018 |
| D-1181-2018 | Class I | Levothyroxine and Liothyronine (Thyroid Tablets, USP), 1/4 grain (15 mg), 100-count bottles, Rx Only | August 3, 2018 |
| D-1178-2018 | Class I | Levothyroxine and Liothyronine (Thyroid Tablets, USP), 1 grain (60 mg), 100-count bottles, Rx Only, | August 3, 2018 |
| D-1180-2018 | Class I | Levothyroxine and Liothyronine (Thyroid Tablets, USP), 1/2 grain (30 mg), 100-count bottles, Rx Only | August 3, 2018 |